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Mental health-related multimorbidity can be considered as
multimorbidity in the presence of a mental disorder. Some
knowledge gaps on the study of mental health-related
multimorbidity were identified. These knowledge gaps
could be potentially addressed with real-world data.
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Mental health-related multimorbidity
Mental disorders are not only the conditions most frequently
included within clusters of chronic diseases, but they may also
have the largest impact on the lives of patients and their families.1
Different studies that examined combinations of chronic conditions
showed that one in three patients with multimorbidity had a coex-
isting mental disorder.1,2 Besides, patients in clusters that contain
mental disorders had worse clinical outcomes, higher premature
mortality and consistently reported poorer quality of life.3 If multi-
morbidity could be defined as the coexistence of two or more long
term or chronic diseases in one individual at a given time point,2,3
Mental health-related multimorbidity (MHRM) can be considered
as multimorbidity in the presence of a mental disorder. However,
despite the relevance of MHRM, its presence and rates can be par-
ticularly difficult to establish because of the overlap in symptoms
between mental disorders, and the limitations of the most
commonly used diagnostic classifications (mainly the DSM and
ICD).1 In this sense, the promotion of a patient-centred approach
and the adoption of multilayered diagnostic systems (dimensional
diagnosis), such as the Research Domain Criteria or the
Hierarchical Taxonomy of Psychopathology, rather than diagnos-
tics based on specific signs and symptoms, could offer a potentially
valuable approach for improving the current knowledge in MHRM.
Within the context of MHRM, as conditions may progress and
become more severe, it is important to determine their trajectories
and the impact on individual health outcomes during the lifespan.2
It should be noted that although the peak of onset of most of mental
disorders is during adolescence and early adulthood, most of the
studies on MHRM are focused on older adults. Moreover, despite
the evidence about the overall health consequences of MHRM,1–3
there is a lack of actionable information that can be translated
into healthcare improvements. Therefore, the study of MHRM, par-
ticularly in early stages of the lifespan, stands as a major research
and clinical priority. Such research will serve to guide the develop-
ment of targeted early interventions, which could help to reduce the
adverse effects of MHRM over their life course.
Multimorbidity and the current healthcare paradigm
The past decades have seen an effort to enhance diagnostic precision
(e.g. through the emergence of multilayered classifications in psy-
chopathology), in an attempt to improve traditional diagnostic
systems such as the DSM and ICD. This has arguably improved
diagnostic accuracy and the effectiveness of treatments, allowing
for the diagnosis of previously underdetected disorders (e.g. atten-
tion-deficit hyperactivity disorder in adults), the prevention andman-
agement of previously fatal diseases (e.g. certain types of cancer) and
increasing the life expectancy and quality of life of patients.
Paradoxically, these advances, together with the ageing of the popula-
tion and its associated increase in the prevalence and incidence of
chronic conditions, may have led to an increase in multimorbidity.2,3
The current healthcare paradigm favours an integrative patient-
centred approach to understanding and managing complex health
problems. This approach posits that the aetiology and outcomes
of diseases are multifactorial and multisystemic. Multimorbidity,
thus, might be attributable to a complex combination of biological
factors (e.g. inflammation), behavioural factors (e.g. diet) and psy-
chosocial factors (e.g. social deprivation).2,3 Whereas an integrative
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approach is promoted by the current healthcare paradigm, clinical
practice and treatments continues to be focussing predominantly on
individual conditions. In addition, there is currently no explicit
approach for how to integrate the diverse, and often overlapping, clin-
ical guidance for themanagement of specific physical andmental con-
ditions. The development and promotion of evidence-based clinical
guidelines focused on MHRM, which account for a wider range of
determinants, might facilitate an integrative patient-centred approach.
Real-world data and MHRM
Real-world data (RWD), a popular concept in medical science in
recent years, can be defined as observational data that capture
healthcare outcomes in real-world settings, from heterogeneous
populations and from different data sources.4 However, the type
of studies included under the umbrella RWD concept can vary
according to how the concept is interpreted.4 Although some inter-
pretations encompass a broad range of study designs, including ran-
domised controlled trials, RWD is most frequently interpreted as
referring only to data from sources with inclusion criteria that are
not as strict as those of clinical trials. Despite this heterogeneity,
there is some consensus that two of the most relevant data
sources for RWD are electronic health records (EHRs) and observa-
tional studies including cohort data.4
Rapid progress in the adoption and use of EHRs has resulted in
large amounts of routinely collected clinical data becoming available
for use in health research. The comprehensive nature of these data
affords identification of complex patterns of multimorbidity and
related burden. To date, several large data-sets comprising routine
clinical data have been developed, offering an opportunity to shed
light on different aspects of MHRM,4 such as the Clinical Practice
Research Datalink (CPRD) in the UK, or Medicare claims data in
the USA. Although comprehensive and in some cases representa-
tive, data from EHRs come with certain limitations around their
completeness, accuracy and access. These data reflect clinical prac-
tice, meaning that non-clinical information, such as social determi-
nants and life events, is often poorly captured. Similarly, mental
disorders are often underdetected and underrecorded in primary
care settings, a common source of EHR data in some countries, such
as the UK (e.g. CPRD, QResearch databases, the Royal College of
General Practitioners Research and Surveillance Centre sentinel
network, and the East London Health and Care Partnership Data
Repository). Furthermore, EHR data accessibility and linkage are far
from straightforward processes in specific contexts, often impeded
by legal and bureaucratic issues. Improving both access to EHRs, as
proposed by countries such as Denmark and Sweden, and their
linkage with other administrative data-sets (e.g. social care records or
national insurance records) by using shared identification numbers,
might be different strategies to overcome some of the current limita-
tions. In addition, upscaling EHRs to include relevant patient-reported
outcomes and risk factors could improve the quality of the data for the
study of the causes and consequences of MHRM.
Within the umbrella of RWD,4 prospective epidemiological
cohort studies are a complementary data source to evaluate
complex processes, determinants and outcomes associated with
MHRM. As strengths of cohort data, it should be mentioned that
they usually include valid and reliable tools to assess different
health conditions and collect detailed data on social determinants
of health and patient-reported outcomes. Besides, harmonisation
of measures across different cohort data enables sufficiently
powered studies to identify modifiable processes underlying
MHRM.5 However, cohort data also have limitations, and one of
them is related to the accessibility to the samples and the possible
selection bias. Patients with severe mental disorders (e.g.
schizophrenia, dementia and dissociative disorders) are usually dif-
ficult to recruit in cohort studies (e.g. because of a lack of insight into
their disorders or cognitive distortion and disorganisation), placing
constraints on the ability of their data to identify less common
(albeit clinically important) patterns of MHRM, and placing
certain constraints around the external validity of their findings.
Additionally, even in larger and well-supported cohort studies, the
statistical power to detect MHRM patterns declines over time,
because of attrition rates. To overcome these limitations, one feas-
ible alternative could be the use of data from EHRs as they
usually include entire populations continuously followed. Thus, a
coordinated analysis using EHRs alongside pooled cohort data
might be one approach to minimise some of their individual limita-
tions and bring together their strengths.
Opportunities and implications
Mitigating the personal and health consequences of MHRM is contin-
gent on elucidating the drivers of its onset, maintenance and aggrava-
tion, and the use of RWD might facilitate this. For researchers, the
use of RWD could help to identify the drivers of MHRM, and
further understanding of trajectories and underlying mechanisms.
This could then inform the design of specific preventive interventions
and treatments for clusters of pathologies that could improve the
results of those treatments designed for specific diseases. For clinicians,
this knowledge will serve to enhance diagnostic accuracy, improve clin-
ical decision-making and delivermore effective and efficient treatments
adapted and focused on the individual during their lifespan. Finally, for
patients, using RWD in the study of MHRM could help to prevent its
progression and potential consequences, enhance the results of their
treatments and, consequently, improve their quality of life.
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